Loading organizations...
Health2047 operates as a venture studio, building and scaling early-stage companies for systemic change in U.S. healthcare. The firm conceives, funds, and launches new ventures, using technological innovation to reshape care models. Its approach addresses industry challenges by creating solutions for improved efficiency and enhanced patient experiences.
The American Medical Association established Health2047, driven by the insight that proactive change in healthcare delivery was essential. This led to a dedicated entity to incubate and accelerate new enterprises. The AMA's strategic move combines its deep industry understanding with an entrepreneurial mandate to foster innovation.
Health2047 partners with founders and investors committed to advancing healthcare solutions. Its portfolio companies serve the broader ecosystem, aiming for more affordable care and superior patient outcomes. The long-term vision is to foster enterprises that drive fundamental improvements across the healthcare continuum, ensuring a more accessible and effective system.
Key people at Health2047.
Health2047 has 2 tracked investments across 2 companies. The latest tracked deal is $7.8M Grant / Series A in Phenomix in May 2024.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| May 16, 2024 | Phenomix | $7.8M Grant / Series A | — | Dexcom Ventures, Labcorp, National Institutes OF Health |
| Feb 14, 2022 | PriorAuthNow, Inc. | $25.0M Other Equity | JON Rosenbaum | Mark Buffington |
Key people at Health2047.